title: [Drugs having latex and therapeutic alternatives in hospital formulary].
abstract: OBJECTIVE
  To analyze the latex content of drugs in hospital formulary and establish possible therapeutic alternatives.
  
  
  METHODS
  All drugs susceptible of having latex were selected and written information was obtained from manufacturers. A therapeutic alternative was found for each of them, if possible.
  
  
  RESULTS
  Written information from manufacturer was obtained for 605 (97.9%) and from label information for 8 of 632 selected drugs. For 43.9% of not safe drugs (total 57) on patients with latex allergy, a therapeutic alternative was found in hospital formulary.
  
  
  CONCLUSIONS
  Knowing drugs having latex improve the prescription security, while the therapeutic alternatives chart eases the validation. The published data updates the scarce and variable information for patients and healthcare professionals.
authors: Servicio de Farmacia. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria.. rosadamasfuentes@gmail.com.
authors: Rosa María
authors: RM
authors: Damas Fuentes
authors: Servicio de Farmacia. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria..
authors: Moisés
authors: M
authors: Pérez León
authors: Servicio de Farmacia. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria..
authors: Marta
authors: M
authors: Piñero González
authors: Servicio de Farmacia. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria..
authors: Nayra
authors: N
authors: Sangil Monroy
authors: Servicio de Farmacia. Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria..
authors: Rafael
authors: R
authors: Molero Gómez
authors: Farmacéutico comunitario, Las Palmas de Gran Canaria. España..
authors: Pablo
authors: P
authors: Domínguez Lantigua
mesh_terms: D016208:Databases, Factual; D005572:Formularies, Hospital as Topic; D006801:Humans; D007840:Latex / Q000009:adverse effects / Q000032:analysis*; D020315:Latex Hypersensitivity / Q000517:prevention & control
chemical_list: D007840:Latex